Arkolith/Insider Trading/IMNM/Form 4

Rosett Max

Chief Financial OfficerImmunome Inc. (IMNM) · full profile →Form 4 · filed Sep 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$230K
Net Open-Market Flow
-$230K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2024Sell(S)14K$16.01$230K47K
Sep 19, 2024Option exercise(M)42K$1.05$44K62K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 19, 2024Option exercise(M)42K—$092K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-023809) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML